デフォルト表紙
市場調査レポート
商品コード
1452772

脱パイロジェン滅菌空バイアルの世界市場規模、シェア、成長分析、バイアル別、エンドユーザー別 - 産業予測(2024~2031年)

Global Depyrogenated Sterile Empty Vials Market Size, Share, Growth Analysis, By Vial(Glass and plastic), By End-user(Pharmaceuticals, biotechnology) - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
脱パイロジェン滅菌空バイアルの世界市場規模、シェア、成長分析、バイアル別、エンドユーザー別 - 産業予測(2024~2031年)
出版日: 2024年03月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

脱パイロジェン滅菌空バイアルの世界市場規模は、2022年に1,340億米ドルと評価され、2023年の1,431億1,000万米ドルから2031年には2,422億4,000万米ドルに成長し、予測期間(2024-2031年)のCAGRは6.80%で成長する見通しです。

製薬およびバイオテクノロジー産業で不可欠な脱パイロジェン滅菌空バイアルの世界市場は、無菌包装の需要増加により拡大しています。副作用の原因となるパイロジェン(発熱性物質)を含まないこれらのバイアルは、製品の安全性を確保する上で極めて重要です。医薬品開発、ワクチン製造、生物製剤の増加などの要因が市場開拓を後押ししています。メーカーは品質コンプライアンス、技術の進歩、汚染リスクの低減に注力しています。ヘルスケア分野が成長する中、脱パイロジェン滅菌空バイアル市場は持続的な成長を遂げ、安全なドラッグの保管とデリバリーにおいて重要な役割を果たしています。さらに、持続可能性への動向も市場に影響を与える可能性があります。メーカーは、環境に優しい包装材料、効率的なエネルギー消費、廃棄物発生の削減を模索している可能性があります。製薬会社とバイアル瓶メーカーのコラボレーションにより、製品の完全性を維持しながら二酸化炭素排出量を最小限に抑える包装ソリューションが生まれるかもしれません。

目次

エグゼクティブサマリー

  • 市場概要
  • 運命の輪

調査手法

  • 情報調達
  • セカンダリおよびプライマリデータソース
  • 市場規模の推定
  • 市場の前提条件と制限

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

脱パイロジェン滅菌空バイアルの世界市場:バイアル別

  • 市場概要
  • ガラスとプラスチック

脱パイロジェン滅菌空バイアルの世界市場:エンドユーザー別

  • 市場概要
  • 医薬品
  • バイオテクノロジー
  • 研究室

脱パイロジェン滅菌空バイアルの世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2021年)
  • 主な市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2021年)

主要企業プロファイル

  • SCHOTT AG-Germany
  • Gerresheimer AG-Germany
  • Stevanato Group-Italy
  • SGD Pharma-France
  • Nipro Corporation-Japan
  • West Pharmaceutical Services, Inc.-USA
  • Corning Incorporated-USA
  • Piramal Glass-India
  • Bormioli Pharma-Italy
  • Pacific Vial-USA
  • YPSOMED AG-Switzerland
  • Arab Pharmaceutical Glass Co.(APG)-Saudi Arabia
  • Shandong Pharmaceutical Glass Co., Ltd.-China
  • Hindusthan National Glass & Industries Ltd.-India
  • Triveni Polymers Pvt. Ltd.-India
  • Amposan S.A.-Argentina
  • Consol Glass-South Africa
  • SGD S.A.S-France
  • Global Pharmatech Pvt. Ltd.-India
  • Stevanato Group Engineering Systems-Italy
目次
Product Code: SQMIG35B2151

Global Depyrogenated Sterile Empty Vials Market size was valued at USD 134.0 billion in 2022 and is poised to grow from USD 143.11 billion in 2023 to USD 242.24 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).

The global market for depyrogenated sterile empty vials, essential in pharmaceutical and biotech industries, is expanding due to increased demand for aseptic packaging. These vials, which lack pyrogens that can cause adverse reactions, are crucial for ensuring product safety. Factors such as rising drug development, vaccine production, and biologics are driving market growth. Manufacturers are focusing on quality compliance, technological advancements, and reducing contamination risks. With the healthcare sector growing, the depyrogenated sterile empty vials market is set for sustained growth, playing a key role in safe drug storage and delivery. Additionally, there is a trend toward sustainability, potentially influencing the market. Manufacturers may be exploring eco-friendly packaging materials, efficient energy consumption, and reduced waste generation. Collaborations between pharmaceutical companies and vial manufacturers may lead to packaging solutions that minimize carbon footprint while maintaining product integrity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Depyrogenated Sterile Empty Vials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Depyrogenated Sterile Empty Vials Market Segmental Analysis

The global market for depyrogenated sterile empty vials is segmented based on vial, end-use industry, and region. Vial types include glass and plastic. End-use industries encompass pharmaceuticals, biotechnology, and research laboratories. Geographically, the market is divided into regions such as North America, Europe, Asia-Pacific, and the rest of the world.

Drivers of the Global Depyrogenated Sterile Empty Vials Market

The expansion of the pharmaceutical sector fuels the need for depyrogenated sterile empty vials, essential for packaging injectable drugs, vaccines, and other parenteral products. With the world's population on a continuous rise and aging, the demand for pharmaceutical items is poised to surge, consequently elevating the requirement for related packaging supplies.

Restraints in the Global Depyrogenated Sterile Empty Vials Market

The production of depyrogenated sterile empty vials necessitates intricate procedures and stringent quality assurance protocols, contributing to heightened manufacturing expenses. Moreover, within the pharmaceutical sector's competitive landscape, pricing pressures may arise, potentially diminishing the profitability of vial manufacturers and impeding market expansion.

Market Trends of the Global Depyrogenated Sterile Empty Vials Market

The demand for depyrogenated sterile empty vials, crucial in the pharmaceutical sector for packaging injectable drugs, appears intricately tied to ongoing research and development efforts within the industry. With a growing emphasis on sterile packaging to guarantee drug safety, the need for these vials likely experiences a sustained increase. This surge in demand could be attributed to advancements in biologics, vaccines, and specialized medications, all necessitating stringent sterile packaging protocols to maintain product integrity and patient safety.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Depyrogenated Sterile Empty Vials Market by Vial

  • Market Overview
  • Glass and plastic

Global Depyrogenated Sterile Empty Vials Market by End-user

  • Market Overview
  • Pharmaceuticals
  • biotechnology
  • and research laboratories

Global Depyrogenated Sterile Empty Vials Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • SCHOTT AG - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gerresheimer AG - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stevanato Group - Italy
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGD Pharma - France
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation - Japan
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • West Pharmaceutical Services, Inc. - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corning Incorporated - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Piramal Glass - India
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bormioli Pharma - Italy
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Vial - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • YPSOMED AG - Switzerland
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arab Pharmaceutical Glass Co. (APG) - Saudi Arabia
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shandong Pharmaceutical Glass Co., Ltd. - China
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hindusthan National Glass & Industries Ltd. - India
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Triveni Polymers Pvt. Ltd. - India
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amposan S.A. - Argentina
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Consol Glass - South Africa
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGD S.A.S - France
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Global Pharmatech Pvt. Ltd. - India
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stevanato Group Engineering Systems - Italy
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments